SGLT-2 INHIBITORS OR IL-1R ANTAGONISTS FOR REDUCTION OF HYPOGLYCAEMIA IN PREDIABETES

摘要

The present invention relates to the use of SGLT-2 inhibitors and/or interleukin-1-receptor antagonists or non-agonist antibodies reactive to interleukin-1β or IL-1 receptor and IL-1 accessory protein in the treatment of prevention of postprandial (or reactive) hypoglycaemia in prediabetes.